Sara L Van Driest1,2, Edmund H Jooste3, Yaping Shi4, Leena Choi4, Leon Darghosian2,5, Kevin D Hill3, Andrew H Smith1, Prince J Kannankeril1, Dan M Roden2,6,7, Lorraine B Ware2,8. 1. Department of Pediatrics, Vanderbilt University School of Medicine, Nashville, Tennessee. 2. Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee. 3. Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina. 4. Department of Biostatistics, Vanderbilt University School of Medicine, Nashville, Tennessee. 5. Cardiovascular Perfusion Technology Program, Vanderbilt University Medical Center, Nashville, Tennessee. 6. Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, Tennessee. 7. Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee. 8. Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tennessee.
Abstract
Importance: Acute kidney injury (AKI) is a common and serious complication for pediatric cardiac surgery patients associated with increased morbidity, mortality, and length of stay. Current strategies focus on risk reduction and early identification because there are no known preventive or therapeutic agents. Cardiac surgery and cardiopulmonary bypass lyse erythrocytes, releasing free hemoglobin and contributing to oxidative injury. Acetaminophen may prevent AKI by reducing the oxidation state of free hemoglobin. Objective: To test the hypothesis that early postoperative acetaminophen exposure is associated with reduced risk of AKI in pediatric patients undergoing cardiac surgery. Design, Setting, and Participants: In this retrospective cohort study, the setting was 2 tertiary referral children's hospitals. The primary and validation cohorts included children older than 28 days admitted for cardiac surgery between July 1, 2008, and June 1, 2016. Exclusion criteria were postoperative extracorporeal membrane oxygenation and inadequate serum creatinine measurements to determine AKI status. Exposures: Acetaminophen exposure in the first 48 postoperative hours. Main Outcomes and Measures: Acute kidney injury based on Kidney Disease: Improving Global Outcomes serum creatinine criteria (increase by ≥0.3 mg/dL from baseline or at least 1.5-fold more than the baseline [to convert to micromoles per liter, multiply by 88.4]) in the first postoperative week. Results: The primary cohort (n = 666) had a median age of 6.5 (interquartile range [IQR], 3.9-44.7) months, and 341 (51.2%) had AKI. In unadjusted analyses, those with AKI had lower median acetaminophen doses than those without AKI (47 [IQR, 16-88] vs 78 [IQR, 43-104] mg/kg, P < .001). In logistic regression analysis adjusting for age, cardiopulmonary bypass time, red blood cell distribution width, postoperative hypotension, nephrotoxin exposure, and Risk Adjustment for Congenital Heart Surgery score, acetaminophen exposure was protective against postoperative AKI (odds ratio, 0.86 [95% CI, 0.82-0.90] per each additional 10 mg/kg). Findings were replicated in the validation cohort (n = 333), who had a median age of 14.1 (IQR, 3.9-158.2) months, and 162 (48.6%) had AKI. Acetaminophen doses were 60 (95% CI, 40-87) mg/kg in those with AKI vs 70 (95% CI, 45-94) mg/kg in those without AKI (P = .03), with an adjusted odds ratio of 0.91 (95% CI, 0.84-0.99) for each additional 10 mg/kg. Conclusions and Relevance: These results indicate that early postoperative acetaminophen exposure may be associated with a lower rate of AKI in pediatric patients who undergo cardiac surgery. Further analysis to validate these findings, potentially through a prospective, randomized trial, may establish acetaminophen as a preventive agent for AKI.
Importance: Acute kidney injury (AKI) is a common and serious complication for pediatric cardiac surgery patients associated with increased morbidity, mortality, and length of stay. Current strategies focus on risk reduction and early identification because there are no known preventive or therapeutic agents. Cardiac surgery and cardiopulmonary bypass lyse erythrocytes, releasing free hemoglobin and contributing to oxidative injury. Acetaminophen may prevent AKI by reducing the oxidation state of free hemoglobin. Objective: To test the hypothesis that early postoperative acetaminophen exposure is associated with reduced risk of AKI in pediatric patients undergoing cardiac surgery. Design, Setting, and Participants: In this retrospective cohort study, the setting was 2 tertiary referral children's hospitals. The primary and validation cohorts included children older than 28 days admitted for cardiac surgery between July 1, 2008, and June 1, 2016. Exclusion criteria were postoperative extracorporeal membrane oxygenation and inadequate serum creatinine measurements to determine AKI status. Exposures: Acetaminophen exposure in the first 48 postoperative hours. Main Outcomes and Measures: Acute kidney injury based on Kidney Disease: Improving Global Outcomes serum creatinine criteria (increase by ≥0.3 mg/dL from baseline or at least 1.5-fold more than the baseline [to convert to micromoles per liter, multiply by 88.4]) in the first postoperative week. Results: The primary cohort (n = 666) had a median age of 6.5 (interquartile range [IQR], 3.9-44.7) months, and 341 (51.2%) had AKI. In unadjusted analyses, those with AKI had lower median acetaminophen doses than those without AKI (47 [IQR, 16-88] vs 78 [IQR, 43-104] mg/kg, P < .001). In logistic regression analysis adjusting for age, cardiopulmonary bypass time, red blood cell distribution width, postoperative hypotension, nephrotoxin exposure, and Risk Adjustment for Congenital Heart Surgery score, acetaminophen exposure was protective against postoperative AKI (odds ratio, 0.86 [95% CI, 0.82-0.90] per each additional 10 mg/kg). Findings were replicated in the validation cohort (n = 333), who had a median age of 14.1 (IQR, 3.9-158.2) months, and 162 (48.6%) had AKI. Acetaminophen doses were 60 (95% CI, 40-87) mg/kg in those with AKI vs 70 (95% CI, 45-94) mg/kg in those without AKI (P = .03), with an adjusted odds ratio of 0.91 (95% CI, 0.84-0.99) for each additional 10 mg/kg. Conclusions and Relevance: These results indicate that early postoperative acetaminophen exposure may be associated with a lower rate of AKI in pediatric patients who undergo cardiac surgery. Further analysis to validate these findings, potentially through a prospective, randomized trial, may establish acetaminophen as a preventive agent for AKI.
Authors: Monika Miklaszewska; Przemysław Korohoda; Alina Sobczak; Anna Horbaczewska; Agata Filipiak; Katarzyna Zachwieja; Krzysztof Kobylarz; Marcin Tkaczyk; Dorota Drożdż; Jacek A Pietrzyk Journal: Kidney Blood Press Res Date: 2014-05-09 Impact factor: 2.687
Authors: Nicolas L Madsen; Stuart L Goldstein; Trine Frøslev; Christian F Christiansen; Morten Olsen Journal: Kidney Int Date: 2017-04-12 Impact factor: 10.612
Authors: Scott A Simpson; Hayden Zaccagni; David P Bichell; Karla G Christian; Bret A Mettler; Brian S Donahue; L Jackson Roberts; Mias Pretorius Journal: Pediatr Crit Care Med Date: 2014-07 Impact factor: 3.624
Authors: Omar Alkandari; K Allen Eddington; Ayaz Hyder; France Gauvin; Thierry Ducruet; Ronald Gottesman; Véronique Phan; Michael Zappitelli Journal: Crit Care Date: 2011-06-10 Impact factor: 9.097
Authors: Melanie Meersch; Christoph Schmidt; Hugo Van Aken; Jan Rossaint; Dennis Görlich; Dirk Stege; Edward Malec; Katarzyna Januszewska; Alexander Zarbock Journal: PLoS One Date: 2014-10-24 Impact factor: 3.240
Authors: Sung Woo Lee; Mi-Yeon Yu; Hajeong Lee; Shin Young Ahn; Sejoong Kim; Ho Jun Chin; Ki Young Na Journal: PLoS One Date: 2015-10-15 Impact factor: 3.240
Authors: Andrea L Conroy; Robert O Opoka; Paul Bangirana; Richard Idro; John M Ssenkusu; Dibyadyuti Datta; James S Hodges; Catherine Morgan; Chandy C John Journal: BMC Med Date: 2019-05-21 Impact factor: 8.775
Authors: Ruth Namazzi; Anthony Batte; Robert O Opoka; Paul Bangirana; Andrew L Schwaderer; Zachary Berrens; Dibyadyuti Datta; Michael Goings; John M Ssenkusu; Stuart L Goldstein; Chandy C John; Andrea L Conroy Journal: EClinicalMedicine Date: 2022-02-12
Authors: Anthony Batte; Zachary Berrens; Kristin Murphy; Ivan Mufumba; Maithri L Sarangam; Michael T Hawkes; Andrea L Conroy Journal: Int J Nephrol Renovasc Dis Date: 2021-07-08
Authors: Antti Valtola; James D Morse; Pawel Florkiewicz; Heidi Hautajärvi; Pasi Lahtinen; Tadeusz Musialowicz; Brian J Anderson; Veli-Pekka Ranta; Hannu Kokki Journal: J Drug Assess Date: 2020-07-28